000 | 00923 a2200277 4500 | ||
---|---|---|---|
005 | 20250512070402.0 | ||
264 | 0 | _c19860918 | |
008 | 198609s 0 0 eng d | ||
022 | _a0149-2918 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aColaizzi, J L | |
245 | 0 | 0 |
_aCritical therapeutic categories: a contraindication to generic substitution? _h[electronic resource] |
260 |
_bClinical therapeutics _c1986 |
||
300 |
_a370-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPharmaceutical Preparations _xmetabolism |
650 | 0 | 4 | _aTherapeutic Equivalency |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aLowenthal, D T | |
773 | 0 |
_tClinical therapeutics _gvol. 8 _gno. 4 _gp. 370-9 |
|
999 |
_c3736908 _d3736908 |